Viewing nowCombinationValsartan Amlofin Tablet 5/80 Milligrams
Valsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.

MFDS item code 201308565 · Approved 2013.07.31 · Insurance code 648103300
Treatment of essential hypertension not adequately controlled with monotherapy
This medication is used to effectively control the blood pressure of patients with essential hypertension whose blood pressure is not sufficiently controlled with monotherapy of amlodipine or valsartan.
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that the tablet be taken at the same time each day (e.g., in the morning). It is recommended that the doses of the individual components (amlodipine or valsartan) be adjusted before this medicine is administered. However, if blood pressure is not controlled with monotherapy with the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 mg or valsartan 80 mg. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 mg or valsartan 160 mg. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 10 mg or valsartan 160 mg, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater). This medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Individuals with allergies to the active ingredients or similar class of medications, pregnant or breastfeeding women, and those with severe kidney or liver dysfunction should not take this medication. Patients with low sodium or fluid levels in the body may experience hypotension, so their condition should be managed prior to administration and blood pressure must be carefully monitored during treatment. Patients with high potassium levels may experience increased potassium levels when taking this medication with potassium supplements or potassium-sparing diuretics, so frequent blood tests are necessary. Patients with renal vascular issues or those who have recently undergone kidney transplantation should consult with a physician before taking this medication, and kidney function should be carefully monitored during treatment. This medication can cause angioedema, such as swelling of the face, lips, or tongue, so if these symptoms occur, use should be discontinued and healthcare professionals should be notified immediately. Patients with heart failure or post-myocardial infarction should frequently check kidney function and blood pressure while taking this medication, as swelling may worsen in some patients with heart failure, requiring caution. This medication may interact with other blood pressure-lowering drugs, so if other medications are being taken concurrently, it is essential to inform a doctor or pharmacist. Caution should be exercised when driving or operating machinery as dizziness or fatigue may occur. In case of overdose, severe hypotension or arrhythmias may occur, so the prescribed dosage must be followed, and if an overdose is suspected, immediate medical attention should be sought. This medication is not recommended for children under 18 years of age as safety and efficacy in this group have not been sufficiently established. Elderly patients may generally receive the standard dose; however, careful observation considering their physical condition is advisable.
Pharyngitis, Influenza, Hypersensitivity, Visual Impairment, Anxiety, Headache, Dizziness, Drowsiness, Postural Dizziness, Paresthesia, Vertigo, Tinnitus, Tachycardia, Palpitations, Syncope, Orthostatic Hypotension, Hypotension, Cough, Pharyngeal and Laryngeal Pain, Diarrhea, Nausea, Abdominal Pain, Constipation, Dry Mouth, Rash, Erythema, Hyperhidrosis, Rash, Itching, Joint Swelling, Low Back Pain, Arthritis, Muscle Spasm, Lethargy, Pollakiuria, Polyuria, Erectile Dysfunction, Edema, Ankle Edema, Facial Edema, Peripheral Edema, Fatigue, Flushing, Weakness, Facial Flushing, Decrease in Hemoglobin, Decrease in Hematocrit, Neutropenia, Thrombocytopenia, Allergic Reactions Including Serum Sickness, Increased Serum Potassium, Vasculitis, Elevated Liver Function Tests, Angioedema, Myalgia, Renal Failure, Renal Injury, Increased Serum Creatinine, Insomnia, Decreased Libido, Pharyngitis, Rhinitis, Sinusitis, Upper Respiratory Tract Infection, Viral Infection, Intestinal Vascular Edema, Diplopia, Thrombocytopenia, Leukopenia, Allergic Reaction, Hyperglycemia, Insomnia, Mood Changes, Tremors, Sensory Decrease, Taste Disturbance, Peripheral Neuropathy, Hypertonicity, Arrhythmia, Bradycardia, Atrial Fibrillation, Ventricular Tachycardia, Myocardial Infarction, Vasculitis, Dyspnea, Rhinitis, Vomiting, Dyspepsia, Pancreatitis, Gastritis, Gingival Hypertrophy, Hepatitis, Jaundice, Alopecia, Purpura, Skin Depigmentation, Photosensitivity Reaction, Angioedema, Urticaria, Erythema Multiforme, Stevens-Johnson Syndrome, Myalgia, Urinary Disorders, Enuresis, Gynecomastia, Pain, Apathy, Chest Pain, Weight Loss, Weight Gain, Chest Discomfort, Abdominal Discomfort, Gastroesophageal Reflux Disease, Neck Pain, Hypercholesterolemia, Hypoglycemia, Neuroirritability, Stevens-Johnson Syndrome, Chest Pain, Weight Gain, Arthralgia, Skeletal Pain, Rhabdomyolysis, Gingival Hyperplasia, Gastritis
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly sealed container to prevent air or moisture from entering. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius to preserve the efficacy and prevent degradation of the medicine.
Dark yellow round film-coated tablet
28 tablets (7 tablets/Alu-AluX4), 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.